The mission of Invitrox, Inc. is to develop specific therapeutic / theranostic cell-based assays to run on two distinct laser light-scattering platforms. Invitrox utilizes its own proprietary spectrometer technologies to determine presence, source, activation state, and function of cells and cell fragments (microparticles) found in biologic fluids. These proprietary technologies are unique and differentiated from all available existing marketed techniques for cellular analysis.
By advancing its portfolio of clinical assays, Invitrox intends to become a standout “in vitro” diagnostics company, competing initially in the cardiovascular market segment. The Company’s first assays will be optimized for platelet function testing and anti-coagulant drug assessment.